Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment
- PMID: 23278625
- DOI: 10.1111/clr.12088
Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment
Abstract
Objectives: Bisphosphonate-related jaw necrosis (BRONJ) associated with dental implants is a rare but continuously reported complication. To verify clinical and pathological characteristics of BRONJ around dental implants, the present study analyzed clinical, radiographic and histopathological findings of these lesions.
Patients and methods: Nineteen patients were diagnosed with osteonecrosis of the jaw associated with dental implants and treated at our institute from 2008 to 2011. The patients' medical history, demographic features, radiographic, and histopathological findings along with information on bisphosphonates (BP) administration were analyzed.
Results: The majority of BRONJ patients associated with dental implants used oral BP for osteoporosis. The patients were divided into two groups: BP initiation before (n = 16) and after (n = 3) implant surgery. Only three patients (15.8%) could be regarded as "implant surgery-triggered" BRONJ. Many patients (n = 9) showed successful osteointegration after fixture installation to an average of 35 months (11-82 months) until the development of osteonecrosis. The histological features of the lesion showed that the necrotic bone with empty lacunae was infiltrated by inflammatory cells and bacterial colonies. Viable osteocytes were also observed in some areas of the bony specimens. Three types of bone destruction pattern were observed: (i) complete necrosis of the bone around the implant (frozen type), (ii) extensive osteolysis around the implant with or without sequestra (osteolytic type), and (iii) sequestration of bone with an implant maintaining direct implant-bone contact (en block sequestration type). These findings could be existed at the same lesions depending on the degree of local bone destruction and the severity of the infection.
Conclusion: These results and those of others suggested that already osseointegrated dental implants can also cause the osteonecrosis around the implant after BP administration. En block sequestration of bone with implant might be one of the characteristics of implant-related BRONJ, which is different from peri-implantitis-induced bone destruction. The possible role of microcracks in this type of bone destruction needs to be examined further.
Keywords: bisphosphonates; dental implants; jaw; osteonecrosis.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Bisphosphonate-related osteonecrosis associated with dental implants: a microcomputed tomography study.Implant Dent. 2014 Jun;23(3):258-63. doi: 10.1097/ID.0000000000000103. Implant Dent. 2014. PMID: 24819815
-
Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?J Craniofac Surg. 2016 May;27(3):697-701. doi: 10.1097/SCS.0000000000002564. J Craniofac Surg. 2016. PMID: 27092912
-
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.Br J Oral Maxillofac Surg. 2013 Dec;51(8):874-9. doi: 10.1016/j.bjoms.2013.06.011. Epub 2013 Jul 15. Br J Oral Maxillofac Surg. 2013. PMID: 23866309
-
Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.J Oral Maxillofac Surg. 2010 Jul;68(7):1662-6. doi: 10.1016/j.joms.2010.02.037. J Oral Maxillofac Surg. 2010. PMID: 20561470 Review.
-
Dental implications of bisphophonate-related osteonecrosis.Gerodontology. 2012 Sep;29(3):177-87. doi: 10.1111/j.1741-2358.2012.00622.x. Epub 2012 Apr 9. Gerodontology. 2012. PMID: 22486711 Review.
Cited by
-
Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope.Oral Dis. 2022 Sep;28(6):1603-1609. doi: 10.1111/odi.13873. Epub 2021 May 4. Oral Dis. 2022. PMID: 33844402 Free PMC article.
-
Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study.Oral Maxillofac Surg. 2023 Mar;27(1):89-100. doi: 10.1007/s10006-022-01042-5. Epub 2022 Jan 27. Oral Maxillofac Surg. 2023. PMID: 35084584
-
General Diseases Influence on Peri-Implantitis Development: a Systematic Review.J Oral Maxillofac Res. 2016 Sep 9;7(3):e5. doi: 10.5037/jomr.2016.7305. eCollection 2016 Jul-Sep. J Oral Maxillofac Res. 2016. PMID: 27833730 Free PMC article. Review.
-
Dental implants in patients treated with antiresorptive medication - a systematic literature review.Int J Implant Dent. 2016 Dec;2(1):9. doi: 10.1186/s40729-016-0041-7. Epub 2016 Apr 4. Int J Implant Dent. 2016. PMID: 27747701 Free PMC article. Review.
-
Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.Int J Implant Dent. 2021 May 14;7(1):47. doi: 10.1186/s40729-021-00323-0. Int J Implant Dent. 2021. PMID: 33987769 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials